Omeros reported $29.67M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.42M 2.02M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Adma Biologics ADMA:US $ 0.38M 1.39M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Gilead Sciences GILD:US $ 6198M 1371M
Insmed INSM:US $ 36.57M 2.04M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Knight Therapeutics Inc GUD:CN C$ 37.77M 8.9M
MacroGenics MGNX:US 14M 16.74M
Omeros OMER:US $ 29.67M 1.19M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Pfizer PFE:US $ 14163M 2178M
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
United Therapeutics UTHR:US $ 417M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M